30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Ironwood Pharmaceuticals Inc (IRWD)

Track

Over the last 90 days, Ironwood Pharmaceuticals Inc. has seen a net sell-off from insiders, with one transaction totaling $79,596.99. This activity contrasts with a broader market trend where the stock has risen 13.3% in the past 90 days, trading near its 52-week high. The company's last earnings report showed a 0.0% EPS beat or miss.
Stock chart
Ticker: IRWD Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
McHugh Julie
1 sale — total 100,000 USD
Planned sale 16 Jun 2026
Value US$1,092,006.85 | Price 122.01 | Shares 796
Proposed sale 16 Jun 2026
Value US$3,379,014.22 | Price 49.40 | Shares 44,775
Sale 17 Mar 2026
Value US$19,198.00 | Price 3.31 | Shares 5,800
Sale 17 Mar 2026
Value US$20,511,250.00 | Price 3.05 | Shares 6,725,000
Sale 24 Feb 2026
Value US$46,192.86 | Price 3.66 | Shares 12,621
Sale 24 Feb 2026
Value US$41,932.62 | Price 3.66 | Shares 11,457
Sale 24 Feb 2026
Value US$69,733.98 | Price 3.66 | Shares 19,053
Sale 24 Feb 2026
Value US$378,905.16 | Price 3.66 | Shares 103,526
Sale 24 Feb 2026
Value US$41,134.74 | Price 3.66 | Shares 11,239
Sale 23 Feb 2026
Value US$44,013.12 | Price 3.81 | Shares 11,552
Sale 23 Feb 2026
Value US$59,321.70 | Price 3.81 | Shares 15,570
Proposed sale 23 Feb 2026
Value US$138,009.57 | Price 4.61 | Shares 29,937
Sale 23 Feb 2026
Value US$39,955.47 | Price 3.81 | Shares 10,487
Proposed sale 23 Feb 2026
Value US$92,951.43 | Price 4.61 | Shares 20,163
Sale 23 Feb 2026
Value US$66,442.59 | Price 3.81 | Shares 17,439
Proposed sale 23 Feb 2026
Value US$154,564.08 | Price 4.61 | Shares 33,528
Planned sale 23 Feb 2026
Value US$361,024.17 | Price 3.81 | Shares 94,757
Proposed sale 23 Feb 2026
Value US$839,872.85 | Price 4.61 | Shares 182,185
Sale 23 Feb 2026
Value US$39,193.47 | Price 3.81 | Shares 10,287
Proposed sale 23 Feb 2026
Value US$91,162.75 | Price 4.61 | Shares 19,775
Planned sale 5 Jan 2026
Value US$162,913.60 | Price 4.60 | Shares 35,416
Proposed sale 5 Jan 2026
Value US$151,226.32 | Price 4.27 | Shares 35,416
Sale 17 Nov 2025
Value US$19,973.12 | Price 3.32 | Shares 6,016
Proposed sale 17 Nov 2025
Value US$21,311.88 | Price 3.37 | Shares 6,324
Sale 11 Aug 2025
Value US$1,105.44 | Price 0.84 | Shares 1,316
Proposed sale 11 Aug 2025
Value US$1,237.28 | Price 0.88 | Shares 1,406
Sale 11 Aug 2025
Value US$2,390.64 | Price 0.84 | Shares 2,846
Sale 11 Aug 2025
Value US$6,513.36 | Price 0.84 | Shares 7,754
Proposed sale 11 Aug 2025
Value US$7,287.28 | Price 0.88 | Shares 8,281
Sale 11 Aug 2025
Value US$1,062.60 | Price 0.84 | Shares 1,265
Proposed sale 11 Aug 2025
Value US$1,188.88 | Price 0.88 | Shares 1,351
Proposed sale 19 May 2025
Value US$1,660.26 | Price 0.59 | Shares 2,814
Proposed sale 19 May 2025
Value US$8,649.99 | Price 0.59 | Shares 14,661
Sale 16 May 2025
Value US$7,744.74 | Price 0.58 | Shares 13,353
Sale 16 May 2025
Value US$1,486.54 | Price 0.58 | Shares 2,563
Sale 10 Feb 2025
Value US$72,633.44 | Price 1.76 | Shares 41,269
Proposed sale 10 Feb 2025
Value US$82,011.56 | Price 1.94 | Shares 42,274
Sale 10 Feb 2025
Value US$244,752.64 | Price 1.76 | Shares 139,064
Proposed sale 10 Feb 2025
Value US$276,360.76 | Price 1.94 | Shares 142,454
Sale 10 Feb 2025
Value US$68,530.88 | Price 1.76 | Shares 38,938
Proposed sale 10 Feb 2025
Value US$77,384.66 | Price 1.94 | Shares 39,889
Sale 10 Feb 2025
Value US$21,204.48 | Price 1.76 | Shares 12,048
Sale 10 Feb 2025
Value US$21,211.52 | Price 1.76 | Shares 12,052
Proposed sale 10 Feb 2025
Value US$23,953.18 | Price 1.94 | Shares 12,347
Proposed sale 27 Dec 2024
Value US$241,736.00 | Price 4.00 | Shares 60,434
Sale 18 Nov 2024
Value US$44,884.08 | Price 4.08 | Shares 11,001
Proposed sale 18 Nov 2024
Value US$51,375.00 | Price 4.11 | Shares 12,500
Planned sale 18 Nov 2024
Value US$21,868.80 | Price 4.08 | Shares 5,360
Proposed sale 18 Nov 2024
Value US$25,029.90 | Price 4.11 | Shares 6,090
Sale 12 Aug 2024
Value US$13,266.89 | Price 4.27 | Shares 3,107
Sale 12 Aug 2024
Value US$42,315.70 | Price 4.27 | Shares 9,910
Proposed sale 12 Aug 2024
Value US$47,490.30 | Price 4.05 | Shares 11,726
Planned sale 10 Jun 2024
Value US$143,198.14 | Price 6.29 | Shares 22,766
Proposed sale 10 Jun 2024
Value US$144,564.10 | Price 6.35 | Shares 22,766
Sale 7 Jun 2024
Value US$235,144.14 | Price 6.61 | Shares 35,574
Proposed sale 7 Jun 2024
Value US$234,767.00 | Price 6.60 | Shares 35,574
Sale 6 Jun 2024
Value US$282,549.36 | Price 6.36 | Shares 44,426
Proposed sale 6 Jun 2024
Value US$282,490.00 | Price 6.36 | Shares 44,426
Sale 20 May 2024
Value US$112,255.80 | Price 6.45 | Shares 17,404
Proposed sale 20 May 2024
Value US$127,673.92 | Price 6.64 | Shares 19,228
Sale 20 May 2024
Value US$146,576.25 | Price 6.45 | Shares 22,725
Proposed sale 20 May 2024
Value US$166,697.20 | Price 6.64 | Shares 25,105
Sale 20 May 2024
Value US$436,136.10 | Price 6.45 | Shares 67,618
Sale 20 May 2024
Value US$436,136.10 | Price 6.45 | Shares 67,618
Proposed sale 20 May 2024
Value US$496,041.20 | Price 6.64 | Shares 74,705
Sale 20 May 2024
Value US$104,025.60 | Price 6.45 | Shares 16,128
Sale 20 May 2024
Value US$104,025.60 | Price 6.45 | Shares 16,128
Proposed sale 20 May 2024
Value US$118,324.80 | Price 6.64 | Shares 17,820
Buy 6 Mar 2024
Value US$60,204.00 | Price 8.70 | Shares 6,920
Buy 4 Mar 2024
Value US$100,215.92 | Price 9.38 | Shares 10,684
Sale 12 Feb 2024
Value US$588,538.32 | Price 15.24 | Shares 38,618
Sale 12 Feb 2024
Value US$2,699,979.36 | Price 15.24 | Shares 177,164
Sale 12 Feb 2024
Value US$722,071.20 | Price 15.24 | Shares 47,380
Sale 12 Feb 2024
Value US$120,517.92 | Price 15.24 | Shares 7,908
Planned sale 12 Feb 2024
Value US$150,053.04 | Price 15.24 | Shares 9,846
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-16 PlS Planned sale
0.9
McHugh Julie
Non-Executive Director
796 +40.9%
122.01
US$1,092,007 		796 +40.9% 122.01 US$1,092,007
2026-06-16 2026-06-16 PrS Proposed sale
0.9
JULIE MCHUGH

Director

Non-Executive Director
44,775
49.40
US$3,379,014 		44,775 49.40 US$3,379,014
2026-03-17 2026-03-17 S Sale
2.8
DENNER ALEXANDER J
Non-Executive Director
24,127 -14.4%
47.68
US$1,124,881 		24,127 -14.4% 47.68 US$1,124,881
2026-03-17 2026-03-17 S Sale
2.8
DENNER ALEXANDER J
Non-Executive Director
6,725,000 -42.2%
3.05
US$20,511,250 		6,725,000 -42.2% 3.05 US$20,511,250
2026-02-25 2026-02-24 S Sale
4.1
Silver Ronald

Principal Accounting Officer

Officer
12,621 -4.8%
3.66
US$46,193 		12,621 -4.8% 3.66 US$46,193
2026-02-25 2026-02-24 S Sale
3.3
Martini Gregory S.

Chief Financial Officer

Officer
11,457 -6.7%
3.66
US$41,933 		11,457 -6.7% 3.66 US$41,933
2026-02-25 2026-02-24 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
19,053 -5.0%
3.66
US$69,734 		19,053 -5.0% 3.66 US$69,734
2026-02-25 2026-02-24 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
103,526 -6.5%
3.66
US$378,905 		103,526 -6.5% 3.66 US$378,905
2026-02-25 2026-02-24 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
11,239 -5.0%
3.66
US$41,135 		11,239 -5.0% 3.66 US$41,135
2026-02-25 2026-02-23 S Sale
4.1
Silver Ronald

Principal Accounting Officer

Officer
11,552 -4.2%
3.81
US$44,013 		11,552 -4.2% 3.81 US$44,013
2026-02-25 2026-02-23 S Sale
4.2
Shetzline Michael

SVP, CMO, Head-Res&Drug

Officer
15,570 -2.8%
3.81
US$59,322 		15,570 -2.8% 3.81 US$59,322
2026-02-25 2026-02-23 S Sale
3.3
Martini Gregory S.

Chief Financial Officer

Officer
10,487 -5.7%
3.81
US$39,955 		10,487 -5.7% 3.81 US$39,955
2026-02-25 2026-02-23 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
17,439 -4.4%
3.81
US$66,443 		17,439 -4.4% 3.81 US$66,443
2026-02-25 2026-02-23 PlS Planned sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
94,757 -5.6%
3.81
US$361,024 		94,757 -5.6% 3.81 US$361,024
2026-02-25 2026-02-23 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
10,287 -4.4%
3.81
US$39,193 		10,287 -4.4% 3.81 US$39,193
2026-02-20 2026-02-23 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
19,775
4.61
US$91,163 		19,775 4.61 US$91,163
2026-02-20 2026-02-23 PrS Proposed sale
3.3
Martini Gregory S.

Officer

Officer
20,163
4.61
US$92,951 		20,163 4.61 US$92,951
2026-02-20 2026-02-23 PrS Proposed sale
4.2
Shetzline Michael

Officer

Officer
29,937
4.61
US$138,010 		29,937 4.61 US$138,010
2026-02-20 2026-02-23 PrS Proposed sale
4.2
John Minardo

Officer

Officer
33,528
4.61
US$154,564 		33,528 4.61 US$154,564
2026-02-20 2026-02-23 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
182,185
4.61
US$839,873 		182,185 4.61 US$839,873
2026-01-07 2026-01-05 PlS Planned sale
4.1
Silver Ronald

Principal Accounting Officer

Officer
35,416 -11.3%
4.60
US$162,914 		35,416 -11.3% 4.60 US$162,914
2026-01-05 2026-01-05 PrS Proposed sale
4.1
RONALD SILVER

Officer

Officer
35,416
4.27
US$151,226 		35,416 4.27 US$151,226
2025-11-19 2025-11-17 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
6,016 -2.5%
3.32
US$19,973 		6,016 -2.5% 3.32 US$19,973
2025-11-14 2025-11-17 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
6,324
3.37
US$21,312 		6,324 3.37 US$21,312
2025-08-13 2025-08-11 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
1,316 -0.5%
0.84
US$1,105 		1,316 -0.5% 0.84 US$1,105
2025-08-13 2025-08-11 S Sale
4.1
Silver Ronald

Principal Accounting Officer

Officer
2,846 -1.0%
0.84
US$2,391 		2,846 -1.0% 0.84 US$2,391
2025-08-13 2025-08-11 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
7,754 -1.9%
0.84
US$6,513 		7,754 -1.9% 0.84 US$6,513
2025-08-13 2025-08-11 S Sale
3.3
Martini Gregory S.

Chief Financial Officer

Officer
1,265 -0.7%
0.84
US$1,063 		1,265 -0.7% 0.84 US$1,063
2025-08-08 2025-08-11 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
1,406
0.88
US$1,237 		1,406 0.88 US$1,237
2025-08-08 2025-08-11 PrS Proposed sale
3.3
Martini Gregory S.

Officer

Officer
1,351
0.88
US$1,189 		1,351 0.88 US$1,189
2025-08-08 2025-08-11 PrS Proposed sale
4.2
John Minardo

Officer

Officer
8,281
0.88
US$7,287 		8,281 0.88 US$7,287
2025-05-16 2025-05-19 PrS Proposed sale
2.5
Gaskins Tammi L

Officer

Officer
2,814
0.59
US$1,660 		2,814 0.59 US$1,660
2025-05-16 2025-05-19 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
14,661
0.59
US$8,650 		14,661 0.59 US$8,650
2025-05-20 2025-05-16 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
13,353 -1.2%
0.58
US$7,745 		13,353 -1.2% 0.58 US$7,745
2025-05-20 2025-05-16 S Sale
2.5
Gaskins Tammi L

Chief Commercial Officer

Officer
2,563 -1.0%
0.58
US$1,487 		2,563 -1.0% 0.58 US$1,487
2025-02-12 2025-02-10 S Sale
4.2
Shetzline Michael

SVP, CMO, Head-Res&Drug

Officer
41,269 -6.9%
1.76
US$72,633 		41,269 -6.9% 1.76 US$72,633
2025-02-12 2025-02-10 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
139,064 -10.7%
1.76
US$244,753 		139,064 -10.7% 1.76 US$244,753
2025-02-12 2025-02-10 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
38,938 -8.7%
1.76
US$68,531 		38,938 -8.7% 1.76 US$68,531
2025-02-12 2025-02-10 S Sale
4.1
Silver Ronald

Principal Accounting Officer

Officer
12,048 -4.1%
1.76
US$21,204 		12,048 -4.1% 1.76 US$21,204
2025-02-12 2025-02-10 S Sale
3.3
Martini Gregory S.

Chief Financial Officer

Officer
12,052 -6.2%
1.76
US$21,212 		12,052 -6.2% 1.76 US$21,212
2025-02-07 2025-02-10 PrS Proposed sale
3.3
Martini Gregory S.

Officer

Officer
12,347
1.94
US$23,953 		12,347 1.94 US$23,953
2025-02-07 2025-02-10 PrS Proposed sale
4.2
John Minardo

Officer

Officer
39,889
1.94
US$77,385 		39,889 1.94 US$77,385
2025-02-07 2025-02-10 PrS Proposed sale
4.2
Shetzline Michael

Officer

Officer
42,274
1.94
US$82,012 		42,274 1.94 US$82,012
2025-02-07 2025-02-10 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
142,454
1.94
US$276,361 		142,454 1.94 US$276,361
2024-12-27 2024-12-27 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
60,434
4.00
US$241,736 		60,434 4.00 US$241,736
2024-11-20 2024-11-18 S Sale
2.2
Emany Sravan Kumar

SVP, COO and CFO

Officer
11,001 -3.4%
4.08
US$44,884 		11,001 -3.4% 4.08 US$44,884
2024-11-20 2024-11-18 PlS Planned sale
3.7
Davis Andrew

SVP, Chief Business Officer

Officer
5,360 -1.8%
4.08
US$21,869 		5,360 -1.8% 4.08 US$21,869
2024-11-15 2024-11-18 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
6,090
4.11
US$25,030 		6,090 4.11 US$25,030
2024-11-15 2024-11-18 PrS Proposed sale
2.2
Emany Sravan Kumar

Officer

Officer
12,500
4.11
US$51,375 		12,500 4.11 US$51,375
2024-08-14 2024-08-12 S Sale
4.1
Silver Ronald

Principal Accounting Officer

Officer
3,107 -1.9%
4.27
US$13,267 		3,107 -1.9% 4.27 US$13,267
2024-08-14 2024-08-12 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
9,910 -3.4%
4.27
US$42,316 		9,910 -3.4% 4.27 US$42,316
2024-08-09 2024-08-12 PrS Proposed sale
4.2
John Minardo

Officer

Officer
11,726
4.05
US$47,490 		11,726 4.05 US$47,490
2024-06-12 2024-06-10 PlS Planned sale
0.9
McHugh Julie
Non-Executive Director
22,766 -14.0%
6.29
US$143,198 		22,766 -14.0% 6.29 US$143,198
2024-06-10 2024-06-10 PrS Proposed sale
0.9
JULIE MCHUGH

Director

Non-Executive Director
22,766
6.35
US$144,564 		22,766 6.35 US$144,564
2024-06-10 2024-06-07 S Sale
3.6
Moukheibir Catherine
Non-Executive Director
35,574 -42.2%
6.61
US$235,144 		35,574 -42.2% 6.61 US$235,144
2024-06-07 2024-06-07 PrS Proposed sale
3.6
Moukheibir Catherine

Director

Non-Executive Director
35,574
6.60
US$234,767 		35,574 6.60 US$234,767
2024-06-10 2024-06-06 S Sale
3.6
Moukheibir Catherine
Non-Executive Director
44,426 -34.5%
6.36
US$282,549 		44,426 -34.5% 6.36 US$282,549
2024-06-06 2024-06-06 PrS Proposed sale
3.6
Moukheibir Catherine

Director

Non-Executive Director
44,426
6.36
US$282,490 		44,426 6.36 US$282,490
2024-05-22 2024-05-20 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
17,404 -5.6%
6.45
US$112,256 		17,404 -5.6% 6.45 US$112,256
2024-05-22 2024-05-20 S Sale
3.7
Davis Andrew

SVP, Chief Business Officer

Officer
22,725 -7.3%
6.45
US$146,576 		22,725 -7.3% 6.45 US$146,576
2024-05-22 2024-05-20 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
67,618 -5.6%
6.45
US$436,136 		67,618 -5.6% 6.45 US$436,136
2024-05-22 2024-05-20 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
67,618 -5.6%
6.45
US$436,136 		67,618 -5.6% 6.45 US$436,136
2024-05-22 2024-05-20 S Sale
4.2
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
16,128 -3.8%
6.45
US$104,026 		16,128 -3.8% 6.45 US$104,026
2024-05-22 2024-05-20 S Sale
4.2
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
16,128 -3.8%
6.45
US$104,026 		16,128 -3.8% 6.45 US$104,026
2024-05-17 2024-05-20 PrS Proposed sale
3.7
Davis Andrew

Officer

Officer
25,105
6.64
US$166,697 		25,105 6.64 US$166,697
2024-05-17 2024-05-20 PrS Proposed sale
4.2
John Minardo

Officer

Officer
19,228
6.64
US$127,674 		19,228 6.64 US$127,674
2024-05-17 2024-05-20 PrS Proposed sale
4.2
Shetzline Michael

Officer

Officer
17,820
6.64
US$118,325 		17,820 6.64 US$118,325
2024-05-17 2024-05-20 PrS Proposed sale
4.2
MCCOURT Thomas A

Officer; Director

Executive Director
74,705
6.64
US$496,041 		74,705 6.64 US$496,041
2024-03-08 2024-03-06 B Purchase
0.8
Duane Jon R
Non-Executive Director
6,920 +6.1%
8.70
US$60,204 		6,920 +6.1% 8.70 US$60,204
2024-03-06 2024-03-04 B Purchase
2.2
Emany Sravan Kumar

SVP, Chief Financial Officer

Officer
10,684 +3.7%
9.38
US$100,216 		10,684 +3.7% 9.38 US$100,216
2024-02-14 2024-02-12 S Sale
4.2
Shetzline Michael

CMO,SVP,Head-Res&Drug

Officer
38,618 -10.2%
15.24
US$588,538 		38,618 -10.2% 15.24 US$588,538
2024-02-14 2024-02-12 S Sale
4.2
MCCOURT Thomas A

Chief Executive Officer

Executive Director
177,164 -17.5%
15.24
US$2,699,979 		177,164 -17.5% 15.24 US$2,699,979
2024-02-14 2024-02-12 S Sale
4.2
John Minardo

Chief Legal Officer

Officer
47,380 -17.4%
15.24
US$722,071 		47,380 -17.4% 15.24 US$722,071
2024-02-14 2024-02-12 S Sale
4.1
Silver Ronald

Principal Accounting Officer

Officer
7,908 -5.6%
15.24
US$120,518 		7,908 -5.6% 15.24 US$120,518
2024-02-14 2024-02-12 PlS Planned sale
3.7
Davis Andrew

SVP, Chief Business Officer

Officer
9,846 -4.5%
15.24
US$150,053 		9,846 -4.5% 15.24 US$150,053
Explore more

More insider trading research around Ironwood Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America